Hunan Zhonghe Pharmaceutical

Hunan Zhonghe Pharmaceutical is a specialty pharmaceutical company based in Changsha, China, that focuses on the development and large-scale manufacturing of synthetic peptide drugs. A wholly-owned subsidiary of Hybio Pharmaceutical, the company operates advanced GMP-certified production facilities dedicated to both active pharmaceutical ingredients (APIs) and finished dosage forms. Its commercial portfolio includes critical treatments for gastrointestinal emergencies, endocrine disorders, and immune system modulation, such as somatostatin, octreotide acetate, and thymopentin. As a key manufacturing arm, the company supports the broader clinical pipeline of its parent organization while maintaining a strong presence in the Chinese domestic market. Hunan Zhonghe Pharmaceutical is recognized as a high-tech enterprise, contributing to the industrialization of peptide-based therapeutics in the region.